Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

meloxicam

APX-MELOXICAM

meloxicam (APX-MELOXICAM) is a cyclooxygenase-2 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 20
Pipeline programs 3
News articles 0
Drug details — meloxicam
US status
approved
Class
—
Route
ORAL
Patents
20
Programs
3
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

meloxicam (APX-MELOXICAM) is a cyclooxygenase-2 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN meloxicam
Brand APX-MELOXICAM
Mechanism Cyclooxygenase-2 inhibitor
Target Prostaglandin G/H synthase 2
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING
Originator Alphapharm Pty Ltd

Mechanism of action

Cyclooxygenase-2 inhibitor

Primary target: Prostaglandin G/H synthase 2

Approval history

Authority Status Date
FDA approved —
TGA approved —

Pipeline programs

Search pipeline Sponsor programs
  1. AXS-07 (MoSEIC meloxicam and rizatriptan) Phase 3 · Axsome Therapeutics · Migraine
  2. AXS-07 (meloxicam-rizatriptan) Phase 3 · Axsome Therapeutics · Migraine
  3. Meloxicam 15 mg Tablets Phase 1 · Teva Pharma · Healthy

Related & competitor drugs

Browse all drugs
  1. celecoxib Antineoplastic and immunomodulating agents (L01)
  2. etodolac Cyclooxygenase-2 inhibitor
  3. carprofen Cyclooxygenase-2 inhibitor
  4. nabumetone Cyclooxygenase-2 inhibitor
  5. rofecoxib Cyclooxygenase-2 inhibitor
  6. valdecoxib Musculo-skeletal system (M01)

Related patents

Browse patents Alphapharm Pty Ltd patent hub

  1. US 12370196

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12357640

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12128052

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12005118

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11998552

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11944683

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11865117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11844837

    Compositions of a polyorthoester and an organic acid excipient

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11826354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11826370

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11806354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11801250

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 2023302008

    METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

    Expires Wed Sep 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11759522

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11738085

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11712441

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11628173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11617755

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11617756

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11617791

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is meloxicam?

meloxicam (APX-MELOXICAM) is a cyclooxygenase-2 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for meloxicam?

APX-MELOXICAM is a marketed brand name for meloxicam. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of meloxicam?

meloxicam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.